|
|
 |
|
Viewing report
|
|
|
|
Competitor Analysis: Malaria Vaccines
La Merie Publishing, May 2010, Pages: 16
The present Competitive Intelligence Report about Malaria Vaccines provides a competitor evaluation in the field of investigational vaccines against one or more antigens of the Plasmodium (Pl) parasite, especiall of Pl. falciparum, for prophylaxis of Malaria as of May 2010. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
Malaria is a mosquito-borne infectious disease caused by the Plasmodium parasite, especially Pl. falciparum. The parasite is transfected by the bite of a mosquito. Malaria is widespread in tropical and subtropical regions. Each year more than 350 million new cases of Malaria occur, it is one of the world’s most common diseases. People with malaria often experience fever, chills, and flu-like illness. Left untreated, they may develop severe complications and die. Non-profit organizations play a major role in supporting the discovery and development of novel vaccines to fight malaria. Industry partners are sought for production of the vaccine and to provide adjuvants if appropriate. A number of malaria vaccine candidates have entered clinical development, but also many have failed.
The report includes a compilation of currently active projects in development of vaccines targeting antigens of the Plasmodium parasite for prophylaxis of Malaria. In addition, the report lists company-specific R&D pipelines of Malaria Vaccines. Competitor projects are listed in a tabular format providing information on:
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Product Category,
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
Index:
- Malaria Vaccines
- Corporate Malaria Vaccines R&D Pipelines
- About La Merie
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Competitor Analysis: HPV Vaccines
Competitor Analysis - Hepatitis Vaccines
Malaria Vaccines: Commercial Prospects and Landscape Analysis
Competitor Analysis - Dengue Virus Vaccines
Competitor Analysis: Cytomegalovirus (CMV) Vaccines and Therapeutics
Competitor Analysis - Toll-Like Receptor (TLR) Agonists and Antagonists 2010
Competitor Analysis: Influenza Vaccines
Competitor Analysis: Staphylococcus aureus Vaccines and Therapeutics
Competitor Analysis: Toll-Like Receptor (TLR) Agonists & Antagonists
Competitor Analysis: Anthrax Vaccines and Therapeutics
|
|
|
|
